MktsMarkets

Bone Biologics Corp
NASDAQ: BBLGKey statistics
BBLG News
Stories mentioning BBLG from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 142.00 | 256.00 | 188.00 | 192.00 | 424.00 | 1,104 | 430.00 | 350.00 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 805.00 | 734.00 | 715.00 | 748.00 | 1,038 | 1,554 | 951.00 | 810.00 |
| Operating Income (Loss) | (805.00) | (734.00) | (715.00) | (748.00) | (1,038) | (1,554) | (951.00) | (810.00) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (766.00) | (684.00) | (667.00) | (741.00) | (1,017) | (1,521) | (941.00) | (784.00) |
| Earnings Per Share (Basic) | (0.43) | (0.58) | (0.37) | (1.33) | (1.92) | (6.01) | (14.21) | (4.02) |
| Earnings Per Share (Diluted) | (0.43) | (0.58) | (0.37) | (1.33) | (1.92) | (6.01) | (14.21) | (4.02) |
| Weighted Average Shares Outstanding (Basic) | 1,795 | 1,175 | 1,795 | 558.00 | 531.00 | 253.00 | 292.00 | 195.00 |
| Weighted Average Shares Outstanding (Diluted) | 1,795 | 1,175 | 1,795 | 558.00 | 531.00 | 253.00 | 292.00 | 195.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BBLG
Bone Biologics Corp (NASDAQ: BBLG) is a stock listed on the Nasdaq Stock Market under the ticker symbol BBLG. It last traded at $0.3100 (Nov 18, 2026, 11:50 AM ET), up 0.7% on the day. That gives Bone Biologics a market capitalisation of $1.1M.
Over the past 52 weeks BBLG has traded between $0.2700 and $2.39.
For the quarter ended Mar 31, 2026 it reported a net loss of $766.0K.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$766.0K |
| Dec 31, 2025 | — | -$684.0K |
| Sep 30, 2025 | — | -$667.0K |
| Jun 30, 2025 | — | -$741.0K |
From Bone Biologics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…